fludarabine and Mesothelioma

fludarabine has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barbarino, M; Bottaro, M; Cipollini, M; Corrado, A; Dell'Anno, I; Gemignani, F; Giordano, A; Landi, S; Luzzi, L; Martin, SA; Melaiu, O; Melani, A; Paolicchi, E; Silvestri, R	1

Other Studies

1 other study(ies) available for fludarabine and Mesothelioma

Article	Year
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma. Investigational new drugs, 2021, Volume: 39, Issue:3 Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Drug Repositioning; Gene Expression Regulation, Neoplastic; Humans; Mesothelioma; Pleural Neoplasms; Risedronic Acid; STAT1 Transcription Factor; Vidarabine	2021

Article

Year

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.

Investigational new drugs, 2021, Volume: 39, Issue:3

Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Drug Repositioning; Gene Expression Regulation, Neoplastic; Humans; Mesothelioma; Pleural Neoplasms; Risedronic Acid; STAT1 Transcription Factor; Vidarabine

2021